This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purposes of this study are to assesss the efficacy of the Seligine Transdermal System (STS) in the treatment of HIV-associated cognitive impairment and to evaluate the safety of long-term use of STS in subjects with HIV-associated cognitive impairment.
Showing the most recent 10 out of 1085 publications